Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "bristol myers squibb"

Jim Cramer's Top Takeaways: Thor Industries, e.l.f. Beauty, Bristol-Myers Squibb
TheStreet.com

Market Is Rewarding High Growth Stocks - Cramer's Mad Money (9...

There is a lot of growth for recreation vehicles in California. Elf Beauty is good, but expensive. Bristol-Myers is poised to run up. Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, September 27. The ... Seeking Alpha, 5 hours ago
[x]  
Monthly Prescribing Reference

Bristol-Myers and Nektar Therapeutics to explore potential of Opdivo and NKTR-214 combo

Bristol-Myers Squibb ( BMY +0.2%) and Nektar Therapeutics ( NKTR -11.7%) announce a new clinical collaboration to evaluate Bristol-Myers' Opdivo (nivolumab) combined with Nektar's investigational NKTR-214 for the treatment offive tumor types ...
 Seeking Alpha1 day ago Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy  TheStreet.com1 day ago BMS and Nektar Therapeutics to Evaluate the Combination of Opdivo and NKTR-214  American Pharmaceutical Review23 hours ago BMS, Nektar to Assess Opdivo/NKTR-214 Co...  Genetic Engineering News1 day ago
[x]  
Reuters UK

BRIEF-Tianjin Tianyao Pharma's shares to halt trading from Sept 28 pending announcement

Bristol-Myers to test Opdivo with Nektar drug for several cancers Sept 27 Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar ...
 Reuters UK1 day ago Bristol-Myers to test Opdivo with Nektar drug for several cancers  Reuters UK1 day ago BMS and Nektar to pair Opdivo with natural killer cell drug  pharmaphorum22 hours ago BMS, Nektar pair for a series of Opdivo combo trials  FierceBiotech1 day ago
[x]  
Share Market Updates

HC Trending Hot Stocks= Bristol-Myers Squibb Co (BMY), Mast Therapeutics Inc (MSTX)

Shares of Bristol-Myers Squibb Co (NYSE:BMY ) ended Tuesday session in green amid volatile trading. The shares closed up +0.26 points or 0.47 % at $ 55.74 with 8.62 million shares getting traded. Post opening the session at $ 55.68 , the shares hit ...
 Share Market Updates3 hours ago (HC Stocks Summary) Gilead Sciences (GILD), Bristol-Myers Squibb (BMY)  Share Market Updates21 hours ago Oppenheimer & Co. Inc. Decreases Position in Bristol-Myers Squibb Co. (BMY)  WKRB News1 day ago HC Stocks Broker Alerts! Bioline RX Ltd (BLRX), Bristol-Myers Squibb Co (NYSE:BMY)  Share Market Updates2 days ago
[x]  
Business Standard

Syngene opens R&D centre for Amgen in Bangalore

This will be Syngene's fourth such exclusive R&D centre. It already operates dedicated R&D centres for Bristol-Myers Squibb, Abbott Nutrition and Baxter Inc BS B2B Bureau | Bangalore September 6, 2016 Last Updated at 17:32 IST Syngene International, a ...
 Business Standard3 weeks ago
Freshnews.com

NEKTAR THERAPEUTICS : to Host Investor & Analyst Conference Call to Discuss New Clinical Collaboration with Bristol-Myers Squibb

SAN FRANCISCO, Sept. 27, 2016 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced that it will host a conference call to discuss today's announcement of the new clinical collaboration with Bristol-Myers Squibb. The call will begin at 9:00 ...
 4 Traders1 day ago Nektar Therapeutics to Host Investor & Analyst Conference Call to Discuss New Clinical Collaboration with Bristol-Myers Squibb  PR Newswire1 day ago NEKTAR THERAPEUTICS : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)  4 Traders1 day ago
[x]  
Zacks.com

Bristol-Myers Opdivo's Regulatory Application Validated in EU

Bristol-Myers Squibb Company BMY announced that its type II variation application for Opdivo has been validated by the European Medicines Agency (EMA). The company is looking to expand Opdivo's label to include the treatment of locally advanced ...
 Nasdaq1 week ago
[x]  
MyNewsDesk

Global Drugs for Treatment of Multiple Myeloma Market 2016: Janssen, Celgene, Bristol-Myers Squibb, Grunenthal GmbH, Takeda, Novartis

Market.Biz has recently launched new Market Research Report on "Drugs for Treatment of Multiple Myeloma Market" is a in-depth and professional survey on Drugs for Treatment of Multiple Myeloma Market. The research study Global Drugs for Treatment ...
 MyNewsDesk5 hours ago Global Cancer Immunotherapy Market Worth $119.39 Billion by 2021 - Increased Access to Medical Insurance in Developed Countries Boosting Growth - Research and Markets  International Business Times1 day ago Global Gastric Cancer Market Analysis 2016 - Forecast to 2022 - Research and Markets  Digital Journal1 day ago Metastatic Melanoma Market: New Business Opportunities & Investment Research Report 2024  Digital Journal2 days ago
[x]  

Analysts Weekly Ratings Updates for Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb (NYSE: BMY) recently received a number of ratings updates from brokerages and research firms: 9/20/2016 Bristol-Myers Squibb had its price target lowered by analysts at Citigroup Inc. from $75.00 to $70.00. They now have a ...
 American Banking News5 days ago

BRISTOL MYERS SQUIBB : FDAnews Announces -- Future-Proofing Your Clinical Trial Supply Chain Webinar, Sponsored by Prisym ID, Oct. 12, 2016

Future-Proofing Your Clinical Trial Supply Chain Sponsored by Prisym ID **FDAnews Free Webinar** Oct. 12, 2016 -- 11:00 a.m. 12:30 p.m. ET http://info.fdanews.com/future-proofing-your-ct-supply-chain Are current packaging and labeling processes ...
 4 Traders6 days ago FDAnews Announces — Future-Proofing Your Clinical Trial Supply Chain Webinar, Sponsored by Prisym ID, Oct. 12, 2016 September 22, 2016Join Jason James, Senior Manager, Labelling and Innovation, Bristol-M​yers Squibb and Vince Postill, SVP Global Product &  PRWeb6 days ago FDAnews Announces -- Future-Proofing Your Clinical Trial Supply Chain Webinar, Sponsored by Prisym ID, Oct. 12, 2016  International Business Times6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less